Join the 'Birth Control' group to help and get support from people like you.

Birth Control Blog

Use of 'the Pill' Tied to Higher Risk for Rare Brain Cancer

Posted 7 days ago by

THURSDAY, Jan. 22, 2015 – The risk for developing a rare form of brain cancer known as glioma appears to go up with long-term use of hormonal contraceptives such as the Pill, new Danish research suggests. Women under 50 with a glioma "were 90 percent more likely to have been using hormonal contraceptives for five years or more, compared with women from the general population with no history of brain tumor," said study leader Dr. David Gaist. However, the Danish study couldn't prove cause-and-effect, and Gaist stressed that the findings "need to be put in context" for women because "glioma is very rare." How rare? Only five out of every 100,000 Danish women between the ages of 15 and 49 develop the condition each year, according to Gaist, a professor of neurology at Odense University Hospital. He said that figure includes women who take contraceptives such as the birth control pill. So, ... Read more

Related support groups: Birth Control, Contraception, Plan B, Sprintec, Mirena, Implanon, NuvaRing, Provera, Tri-Sprintec, Depo-Provera, Yasmin, Ortho Tri-Cyclen, Loestrin 24 Fe, Microgestin Fe 1/20, Ortho Evra, Lutera, Nexplanon, TriNessa, Mononessa, Nordette

U.S. Birth Rate Continues Decline, CDC Reports

Posted 14 days ago by

THURSDAY, Jan. 15, 2015 – The U.S. birth rate remained at an all-time low in 2013, the U.S. Centers for Disease Control and Prevention reported Thursday. But as the economy continues to improve, births are likely to pick up, experts say. "By 2016 and 2017, I think we'll start seeing a real comeback," said Dr. Aaron Caughey, chair of obstetrics and gynecology for Oregon Health & Science University in Portland. "While the economy is doing better, you're still going to see a lag effect of about a year, and 2014 is the first year our economy really started to feel like it's getting back to normal." More than 3.9 million births occurred in the United States in 2013, down less than 1 percent from the year before, according to the annual report from the CDC's National Center for Health Statistics. The general fertility rate also declined by about 1 percent in 2013 to 62.5 births per 1,000 ... Read more

Related support groups: Birth Control, Contraception

The Pill Remains Most Common Method of Birth Control, U.S. Report Shows

Posted 11 Dec 2014 by

THURSDAY, Dec. 11, 2014 – The pill remains one of the most popular methods of birth control for women, along with female sterilization and condoms, a new report shows. Among the two-thirds of women aged 15 to 44 who used birth control between 2011 and 2013, approximately 16 percent used the pill. Female sterilization, where women have their fallopian tubes closed or blocked, was used by 15.5 percent of women, while 9.4 percent used male condoms, according to the report published Dec. 11 by the U.S. National Center for Health Statistics (NCHS). But intrauterine devices (IUDs) and implants, both types of long-acting reversible contraceptives, are close on the heels of these other forms of birth control, with 7.2 percent of women using them. "Use of long-acting reversible contraceptives is becoming more popular," said report author Kimberly Daniels, of the NCHS. Their use has nearly ... Read more

Related support groups: Birth Control, Contraception, Plan B, Sprintec, Mirena, Implanon, NuvaRing, Provera, Tri-Sprintec, Depo-Provera, Yasmin, Ortho Tri-Cyclen, Loestrin 24 Fe, Microgestin Fe 1/20, Ortho Evra, Lutera, Nexplanon, TriNessa, Mononessa, Nordette

Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate

Posted 1 Oct 2014 by

WEDNESDAY, Oct. 1, 2014 – Giving teenage girls free birth control – especially long-acting implanted devices – could slash pregnancy and abortion rates to well below the current U.S. average, new findings suggest. In a study of 1,400 teenage girls, researchers found that counseling and free contraceptives substantially cut the girls' rates of unplanned pregnancy and abortion. Over three years, their annual pregnancy rate averaged 34 per 1,000 girls – versus a rate of 158 per 1,000 among all sexually active teenage girls in the United States. Meanwhile, the abortion rate was 9.7 per 1,000 girls in the study, compared to a national abortion rate of 41.5 per 1,000 sexually active girls, the researchers report in the Oct. 2 issue of the New England Journal of Medicine. "What we're seeing here are extraordinary declines," said Bill Albert, chief program officer for the Washington, ... Read more

Related support groups: Birth Control, Contraception, Mirena, Implanon, Nexplanon

Pediatricians Endorse IUDs, Implants for Teen Birth Control

Posted 29 Sep 2014 by

MONDAY, Sept. 29, 2014 – Long-acting contraceptive devices should be the first choice of birth control for teenage girls, new recommendations from the American Academy of Pediatrics state. Although most U.S. teens opt for condoms or birth control pills, two other forms of contraception – intrauterine devices (IUDs) and contraceptive implants – are much more reliable, according to the academy. And they should be the "first-line" choices for teenage girls who don't want to remain abstinent, the academy says in guidelines published Sept. 29 in the journal Pediatrics. The advice is in line with guidelines from other medical societies, such as the American College of Obstetricians and Gynecologists. But experts said they hope the official recommendation to pediatricians will increase teenage girls' use of IUDs and implants. The academy's move is "fantastic," said Dr. David Eisenberg, an ... Read more

Related support groups: Birth Control, Contraception

Administration Offers New Rules for Religious Objections to Health Care Law

Posted 22 Aug 2014 by

FRIDAY, Aug. 22, 2014 – Responding to a Supreme Court ruling handed down late in June, the Obama administration on Friday proposed a compromise path that it said would allow women to obtain contraceptives through their health plan, while respecting the views of companies that objected to the provision on religious grounds. "Women across the country deserve access to recommended preventive services that are important to their health, no matter where they work," Health and Human Services Secretary Sylvia Burwell said in an agency news release. "Today's announcement reinforces our commitment to providing women with access to coverage for contraception, while respecting religious considerations raised by nonprofit organizations and closely held for-profit companies." Under the Affordable Care Act health plans must offer at no extra charge all forms of birth control for women that have been ... Read more

Related support groups: Birth Control, Contraception

Some Birth Control Pills May Up Breast Cancer Risk

Posted 1 Aug 2014 by

THURSDAY, July 31, 2014 – Birth control pills containing high doses of estrogen, along with some other formulations, may increase the risk of breast cancer in women under 50, new preliminary research suggests. "There are numerous oral contraceptive formulations," explained lead researcher Elisabeth Beaber, a staff scientist at the Fred Hutchinson Cancer Research Center in Seattle. "Some of these formulations increase breast cancer risk while other formulations do not raise risk." Overall, birth control pill use within the past year was associated with a 50 percent increased risk of breast cancer risk compared with former use or no use of birth control pills, Beaber found. This study was designed to find a possible link between oral contraceptive use and breast cancer risk in younger women. But, it wasn't designed to prove that birth control pills definitively cause the increased risk. ... Read more

Related support groups: Birth Control, Contraception, Plan B, Sprintec, Mirena, Implanon, NuvaRing, Provera, Tri-Sprintec, Depo-Provera, Yasmin, Ortho Tri-Cyclen, Loestrin 24 Fe, Microgestin Fe 1/20, Ortho Evra, Lutera, Nexplanon, TriNessa, Mononessa, Nordette

Supreme Court: Some Companies Don't Have to Cover Birth Control

Posted 30 Jun 2014 by

MONDAY, June 30, 2014 – Family-owned companies don't have to comply with a provision of the Affordable Care Act that requires them to offer insurance coverage for contraception if that requirement violates their religious principles, the U.S. Supreme Court ruled Monday. The 5-4 decision was in response to lawsuits filed by two companies – Hobby Lobby Stores Inc. and Conestoga Wood Specialties Corp. – that argued that the Affordable Care Act's birth control provision ran counter to their religious views. Hobby Lobby Stores is owned by the Green family, who are evangelical Christians. The Oklahoma-based company – with more than 15,000 full-time workers in approximately 600 stores in 41 states – and the Green family said their "religious beliefs prohibit them from providing health coverage for contraceptive drugs and devices that end human life after conception," the Associated Press ... Read more

Related support groups: Birth Control, Contraception

Majority of Americans Support Obamacare Birth Control Provision: Survey

Posted 22 Apr 2014 by

TUESDAY, April 22, 2014 – Nearly 70 percent of Americans support the new health care law's mandated coverage of birth control, a nationwide study finds. University of Michigan researchers surveyed adults in all 50 states and the District of Columbia about universal coverage for birth control, which is being challenged in the U.S. Supreme Court. "There is an ongoing national debate about contraceptive coverage requirements in private health plans in the U.S.," study author Dr. Michelle Moniz, an obstetrician/gynecologist and researcher at the University of Michigan Medical School, said in a university news release. "Our study found that 69 percent of U.S. adults support requiring coverage of birth control in health plans. This indicates that the majority view in the United States is that coverage for contraceptives should be required," she added. The greatest support for this provision ... Read more

Related support groups: Birth Control, Contraception

Mylan Launches Xulane - First Generic Ortho Evra Patch

Posted 18 Apr 2014 by

PITTSBURGH, April 16, 2014 /PRNewswire/ – Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Xulane (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day), the generic version of Janssen Pharmaceuticals Inc.'s Ortho Evra®* (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day). This product is indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Mylan CEO Heather Bresch commented: "Mylan is proud to continue expanding its portfolio of transdermal products through the launch of the first generic Ortho Evra Patch. Mylan's Xulane (Norelgestromin / Ethinyl Estradiol Transdermal ... Read more

Related support groups: Birth Control, Contraception, Ortho Evra, Ethinyl Estradiol/Norelgestromin

Teen Pregnancy Rates Much Higher for Girls With Serious Mental Illness: Study

Posted 10 Feb 2014 by

MONDAY, Feb. 10, 2014 – Teenage girls diagnosed with major mental illness are much more likely to give birth, according to a new study from Canada, suggesting such girls should become a special target for anti-pregnancy efforts, the researchers say. The investigators also found that birth rates haven't dipped as fast in mentally ill girls as they have in other girls, an indication that those with psychological problems may be less affected by overall trends in teen pregnancy. The study doesn't examine statistics from the United States. But study lead author Dr. Simone Vigod, an assistant professor of psychiatry at the University of Toronto, said they are probably similar. "We're doing a good job overall of preventing pregnancy in teenagers, but we need to attend to the fact that girls with major mental health issues are not having the decrease in pregnancy rate that we expect from ... Read more

Related support groups: Birth Control, Contraception

Male Birth Control Shows Promise in Mice

Posted 3 Dec 2013 by

TUESDAY, Dec. 3, 2013 – A safe and effective male birth control pill may be inching closer to reality, according to researchers. In laboratory experiments, mouse sperm was blocked from semen while still allowing for normal sexual activity. Without sperm in the ejaculated semen, there is no chance of fertilizing an egg and achieving pregnancy. But women shouldn't plan to abandon their birth control pills just yet. At least one expert said this new approach, although promising, is not ready for prime time and won't be in the near future. Results of animal studies also don't necessarily translate to humans. For the study, researchers led by Dr. Sabatino Ventura, a senior lecturer at Monash University in Parkville, Australia, genetically knocked out two key proteins in mice. These proteins – alpha-1A adrenoceptor and P2X1-purinoceptor – transport sperm through the urethra when a man ... Read more

Related support groups: Birth Control, Contraception

'The Pill' Tied to Raised Risk of Glaucoma

Posted 18 Nov 2013 by

MONDAY, Nov. 18, 2013 – Taking birth control pills for more than three years may increase a woman's risk of developing the eye disease glaucoma, a new study suggests. The findings are from an investigation involving more than 3,400 women aged 40 and older who took part in the U.S. National Health and Nutrition Examination Survey between 2005 and 2008. "At this point, women who have taken oral contraceptives for three or more years should be screened for glaucoma and followed closely by an ophthalmologist, especially if they have any other existing risk factors," said lead researcher Dr. Shan Lin, professor of clinical ophthalmology at the University of California, San Francisco. Women who took birth control pills for longer than three years were twice as likely to have been diagnosed with glaucoma, according to the study. The findings were presented Monday at the annual meeting of the ... Read more

Related support groups: Birth Control, Contraception, Plan B, Sprintec, Mirena, Implanon, NuvaRing, Provera, Tri-Sprintec, Depo-Provera, Yasmin, Ortho Tri-Cyclen, Loestrin 24 Fe, Microgestin Fe 1/20, Ortho Evra, Lutera, Nexplanon, TriNessa, Mononessa, Nordette

Warner Chilcott Announces FDA Approval of Lo Minastrin Fe

Posted 28 Jul 2013 by

DUBLIN, Ireland, July 25, 2013 – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved Lo Minastrin Fe (norethindrone acetate and ethinyl estradiol chewable tablets, ethinyl estradiol tablets and ferrous fumarate tablets) for the prevention of pregnancy. The Company is currently developing the commercial launch plans for Lo Minastrin Fe. "We are pleased to announce the approval of Lo Minastrin Fe, which marks the fifth FDA-approved product for the Company since the beginning of 2013," noted Roger Boissonneault, President and CEO of Warner Chilcott. About Lo Minastrin Fe Lo Minastrin Fe is indicated for use by females of reproductive age to prevent pregnancy. Important Safety Information Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, ... Read more

Related support groups: Birth Control, Contraception, Ethinyl Estradiol/Norethindrone

FDA Medwatch Alert: Estarylla (norgestimate and ethinyl estradiol): Recall - Report of Placebo Tablet Present in Row of Active Tablets

Posted 8 Jul 2013 by

ISSUE: Sandoz notified the public it is conducting a voluntary nationwide recall to the retailer level of one lot of its Estarylla (norgestimate and ethinyl estradiol) tablets in the US, following a customer report of a placebo tablet present in a row of active tablets on one pack. The lot number, expiration date, and NDC code of the recalled lot is: LF01213A, expiration date 02/2014, NDC 00781-4058-15. It is supplied in cartons containing 3 blister cards of 28 tablets each. This lot was distributed to the US market only. BACKGROUND: Estarylla is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. RECOMMENDATION: The Sandoz Drug Information Direct Line is open at 800-525-2492, 24 hours/day, seven days a week. Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use ... Read more

Related support groups: Birth Control, Contraception, Estarylla

Page 1 2 3 4 5 6 Next

Ask a Question

Further Information

Related Condition Support Groups

Emergency Contraception, Postcoital Contraception, Labor and Delivery including Augmentation

Related Drug Support Groups

Sprintec, Mirena, Implanon, NuvaRing, Provera, Tri-Sprintec, Depo-Provera, Yasmin, Ortho Tri-Cyclen, view more... Loestrin 24 Fe, Microgestin Fe 1 / 20, Ortho Evra, Lutera, Nexplanon, TriNessa, Mononessa, Nordette, Ortho Tri-Cyclen Lo, Seasonique, Yaz, Aviane, medroxyprogesterone, Ocella, Levora, Triphasil, levonorgestrel, Levlen, Sronyx, Lo Loestrin Fe, Jolessa, Cryselle 28, Apri, Beyaz, Ovral, norethindrone, Gianvi, Alesse, Ortho Cyclen, Ogestrel, Previfem, Junel Fe 1 / 20, Kariva, Reclipsen, Jolivette, Necon 1 / 35, Tri-Previfem, Microgestin 1 / 20, Quasense, Low-Ogestrel-28, Ogestrel-28, Ortho Micronor, Nora-Be, Trivora, Errin, Orsythia, Microgestin FE 1.5 / 30, Natazia, generess fe, LoSeasonique, Seasonale, Femhrt, Zovia, Camila, Ovral-28, Safyral, Desogen, Gildess Fe 1 / 20, Portia, Chateal, Lessina, Camrese, Lybrel, Ortho-Cept, Microgestin 1.5 / 30, etonogestrel, Lo / Ovral-28, Azurette, Marlissa, Loestrin 1 / 20, Zarah, Enpresse, Ortho-Novum 7 / 7 / 7, Mircette, Skyla, Amethia, Zenchent, Femcon FE, ethinyl estradiol / levonorgestrel, Lo / Ovral, copper topical, Encare, Triphasil-28, Balziva, Ortho-Novum 1 / 35, Emoquette, ethinyl estradiol / norgestimate, Estarylla, drospirenone / ethinyl estradiol, Mono-Linyah, Tri-Linyah, Cyclessa, Velivet, Syeda, Low-Ogestrel-21, Tilia Fe, Amethyst, Junel Fe 1.5 / 30, Norplant System, Necon 7 / 7 / 7, Ovcon 35, Loestrin Fe 1 / 20, Nor-QD, Leena, Triquilar 28, Nortrel 7 / 7 / 7, Heather, Estrostep Fe, Tri-Estarylla, Viorele, ethinyl estradiol / norelgestromin, Loryna, ethinyl estradiol / norethindrone, Nordette-21, Solia, desogestrel / ethinyl estradiol, Kelnor, Dasetta, Falmina, Altavera, Tri-Legest Fe, Norinyl 1+35, Depo-Provera Contraceptive, Elinest, Junel 1 / 20, Trivora-28, Jencycla, Alesse-28, Xulane, Jevantique, Alesse-21, Gildagia, depo-subQ provera 104, Lyza, Ortho-Novum 1 / 50, Aranelle, Junel 1.5 / 30, Zeosa, Zovia 1 / 50, Demulen, Vestura, Caziant, estradiol / medroxyprogesterone, Ovcon 35 Fe, Tri-Norinyl, Nortrel 1 / 35, Triquilar 21, Zovia 1 / 35, Introvale, Modicon, Necon 1 / 50, nonoxynol 9, Briellyn, ethinyl estradiol / norgestrel, mestranol / norethindrone, Loestrin Fe 1.5 / 30, Tri-Legest, Genora 1 / 50, Levonest, ethinyl estradiol / etonogestrel, Kurvelo, Nortrel 0.5 / 35, Necon 10 / 11, Norethin 1 / 35 E, Norlyroc, Nelova 1 / 35, Wera, ethinyl estradiol / ethynodiol, Jenest, Genora 1 / 35, Ovcon 50, Philith, Myzilra, CamreseLo, Nelova 10 / 11, ethinyl estradiol / folic acid / levonorgestrel, VCF Vaginal Contraceptive, Min-Ovral 28, Min-Ovral 21, Nelova 0.5 / 35, Koromex Contraceptive, Ramses Personal, Shur-Seal Gel, Conceptrol, Loestrin 21 1 / 20, Koromex Crystal Clear Gel, K-Y Plus Nonoxynol 9, Koromex Cream, Nordette-28, Brevicon, Tri-Levlen, Triphasil-21, Levlite, Advantage-S, Genora 0.5 / 35, Ramses Crystal Clear, Demulen 1 / 35, ulipristal, drospirenone / ethinyl estradiol / levomefolate calcium, Norinyl 1+50, Lunelle, Nelova 1 / 50 M, dienogest / estradiol, Norethin 1 / 50 M, Ortho-Novum 10 / 11, Tri-Lo-Sprintec, Loestrin 21 1.5 / 30, Cesia, Delfen Foam, Emko, Demulen 1 / 50, Koromex, Necon 0.5 / 35, Curretab, Amen, Cycrin, octoxynol